WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 359  352  344  337  329  247  188  144 
Births
Surviving infants
Pop. less than 5 years 39  39  38  38  38  37  30  24 
Pop. less than 15 years 117  116  116  116  115  101  82  67 
Female 15-49 years 99  96  94  91  88  61  43  30 

Number of reported cases

(Click for retrospective incidence data for Belize)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  25  607 
Mumps
ChartChart
 
Pertussis
ChartChart
  44  11 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belize)
Vaccine year result method % card seen                                                
BCG 2010  98  MICS   75  98  98  99  98  98  96  93  71 
DTP1 2010  83  MICS   75  97  96  96  96  98  88 
DTP3 2010  74  MICS   75  94  95  95  98  95  91  91  47 
DTP4          86  82 
IPV1          99* 
HepB_BD          99* 
HepB3 2010  74  MICS   75  94  95  95  98  95  76 
Hib3 2010  74  MICS   75  94  95  95  98  95 
JapEnc         
MCV1          96  95  99  96  98  96  86  21 
MCV2          95  92  92  93  98 
PCV1         
PCV3         
Pol3 2010  70  MICS   75  94  95  95  98  95  91  86  44 
Rota1         
RotaC         
Rubella1          96  95  99  96  98 
TT2plus 2010  35  MICS   75  82  87  87  89  89 
PAB         
VAD1          80  55  78  97  83 
YFV          73  79 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belize)
BCG
ChartChart
  98  99  98  98  96  93  71 
DTP1
ChartChart
  96  96  99  98  96  97  72 
DTP3
ChartChart
  95  95  98  95  91  91  47 
HepB3
ChartChart
  95  95  98  95  76 
HepB_BD
ChartChart
 
Hib3
ChartChart
  95  95  98  95 
MCV1
ChartChart
  95  99  96  98  96  86  21 
MCV2
ChartChart
  92  92  93  98 
PAB
ChartChart
  91  88  88  88  85  88 
PCV3
ChartChart
 
Pol3
ChartChart
  95  95  98  95  91  86  44 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 83
From 80 to 89% 17
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6 months; Yes contraindication to the Vaccine
DTwP 4-5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV From October 2016
HepB > 12 years; Yes At risk adults and children
IPV 2, 4, 6 months; 4-5 years; Yes All children at M2, then Infants born to HIV positive mothers
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, pregnant women, health care workers, and other risk groups
Influenza_Pediatric 6-23 months; Yes and children with crhonic diseases
MMR 12, 24 months; Yes
OPV 2, 4, 6 months; 4-5 years; Yes
Rabies 0, 3, 7, 28 days; 6 months; Exposed children and adults
Td 10 years; Yes Children >7 years of age & pregnant women
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF >= 1 year; Yes travelling to endemic countries

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2013-2018  2'015  2010-2016  2010 - 2016  2007-2011     
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 67  83  67  100  50  83  83 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 99  98  95  91  97  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.